Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

about

Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations

P2860

Q58699337-3E0A9A2D-21BC-4E12-8BA5-8D4396034975

P2860

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

Item

http://www.wikidata.org/entity/Q36216479

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@ast

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@en

type

Item

label

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@ast

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@en

prefLabel

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@ast

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@en

P1476

Coagulase negative staphylococ ...... apt vancomycin dose or target?

@en

P2093

Helgi Padari

http://www.w3.org/2001/XMLSchema#string

Krista Lõivukene

http://www.w3.org/2001/XMLSchema#string

Tõnis Tasa

http://www.w3.org/2001/XMLSchema#string

P2860

Drug binding properties of neonatal albumin

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations

Association between vancomycin trough concentration and area under the concentration-time curve in neonates

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units

High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination.

Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci.

Late-onset neonatal sepsis: recent developments.

Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates

P2888

s12887-016-0753-0

P304

206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12887-016-0753-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kersti Oselin

Irja Lutsar

Tuuli Metsvaht

P577

2016-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028360848

http://www.w3.org/2001/XMLSchema#string

P698

27931193

http://www.w3.org/2001/XMLSchema#string

P921

sepsis

P932

5146818

http://www.w3.org/2001/XMLSchema#string

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

about

P2860

P2860

Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932